United States
This webcast gives an overview of the top considerations for life sciences companies looking to repatriate or nearshore supply chains.
With the election approaching, RSM is looking at the economic stakes and the key issues for the life sciences industry.
We suggest stress-testing your supply chain to determine what the actual or opportunity costs of disruption might be.
For companies that may have dealt with a lab closure because of the pandemic, Scientist.com allows research to continue.
Whether developing drug therapies, designing medical devices, or more, life sciences companies have complex technology needs.
Life sciences companies are inherently fast-paced and back-office investments must evolve to match the changing needs of the organization.
More promise, more problems: Cyberattacks threaten life sciences companies researching COVID-19 vaccine.
The IRS updated taxpayers on its operations status and recognized the delays in processing check payments due on July 15, 2020.
Applications to sell unused state net operating losses and state research and development credits available the week of May 1, 2020.
Learn about opportunities for life sciences foreign direct investment (FDI) into the United States with this complimentary webcast.
An update on the economic impacts, kbusiness continuity strategies, and considerations from an audit, tax, VAT and supply chain perspective.
RSM professionals explain the parties involved and information needed for life sciences companies to comply with the federal law.
Here are some ways coronavirus could leave its mark on the global VAT, trade and tariff landscape for the life sciences industry.
The AICPA released the SOC for Supply Chain report to aid organizations with relevant controls to address business risk.
Corporate taxpayers filing a consolidated return have an added layer of rules to navigate when carrying back a net operating loss.
Life sciences companies: Learn the importance of anticipating and managing key risks when working with third parties in our helpful e-book.
The IRS provided long-awaited guidance for taxpayers anxious to take advantage of the NOL provisions in the CARES Act.
Recent guidance provides that certain deadlines, including the allowable time to invest in a QOF, are now extended because of COVID-19.
The IRS issued guidance extending the time for taxpayers to file certain Form 3115s and Form 1128s to July 15, 2020.
As businesses renegotiate debts in the aftermath of COVID-19, it is critical to understand whether the debt is considered publicly traded.